GSK Plc ADR [NYSE: GSK] closed the trading session at $38.64 on 2025-06-19. The day’s price range saw the stock hit a low of $38.58, while the highest price level was $39.52.
The stocks have a year to date performance of 14.25 percent and weekly performance of -7.16 percent. The stock has been moved at 13.81 percent over the last six months. The stock has performed 1.79 percent around the most recent 30 days and changed -2.30 percent over the most recent 3-months.
If compared to the average trading volume of 5.33M shares, GSK reached to a volume of 8171529 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about GSK Plc ADR [GSK]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for GSK shares is $44.23 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on GSK stock is a recommendation set at 2.91. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Berenberg have made an estimate for GSK Plc ADR shares, keeping their opinion on the stock as Hold, with their previous recommendation back on June 03, 2025. While these analysts kept the previous recommendation, Exane BNP Paribas raised their target price to Neutral. The new note on the price target was released on April 15, 2025, representing the official price target for GSK Plc ADR stock.
The Average True Range (ATR) for GSK Plc ADR is set at 0.84, with the Price to Sales ratio for GSK stock in the period of the last 12 months amounting to 1.95. The Price to Book ratio for the last quarter was 4.32, with the Price to Cash per share for the same quarter was set at 2.86. Price to Free Cash Flow for GSK in the course of the last twelve months was 12.36 with Quick ratio for the last quarter at 0.58.
GSK stock trade performance evaluation
GSK Plc ADR [GSK] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -7.16. With this latest performance, GSK shares gained by 1.79% in over the last four-week period, additionally plugging by 13.81% over the last 6 months – not to mention a drop of -4.94% in the past year of trading.
GSK Plc ADR [GSK]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and GSK Plc ADR [GSK] shares currently have an operating margin of 18.02% and a Gross Margin at 71.84%. GSK Plc ADR’s Net Margin is presently recorded at 9.89%.
Return on Equity for this stock inclined to 5.23%, with Return on Assets sitting at 5.23%.
Earnings per share (EPS) analysis for GSK Plc ADR [GSK] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for GSK. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for GSK Plc ADR go to 9.83%.
GSK Plc ADR [GSK]: Institutional Ownership
There are presently around $18.33%, or 18.34%% of GSK stock, in the hands of institutional investors. The top three institutional holders of GSK stocks are: DODGE & COX with ownership of 68.34 million shares, which is approximately 1.6753%. FMR LLC, holding 26.78 million shares of the stock with an approximate value of $$1.03 billion in GSK stocks shares; and FMR LLC, currently with $$803.79 million in GSK stock with ownership which is approximately 0.5119%.
